CD226 and sarcoidosis: Using mass cytometry analysis of immune cell subsets in bronchoalveolar lavage fluid (BALF), the analysis of T and B cells revealed increased levels of CXCR3+ CD226+ CD4+ T cells and the presence of FCRL5+ B cells in sarcoidosis patients with advanced lung lesions (Figure 2A).